Table of Contents Table of Contents
Previous Page  134 / 1084 Next Page
Information
Show Menu
Previous Page 134 / 1084 Next Page
Page Background

Neoscope Study – Trial Design

RT

Cape

Cape Cape

Cape

Cape

Cape

OxCapRT Arm

:

Oxaliplatin 130mg/m

2

Day1 + Capecitabine 625mg/m

2

bd Day 1- 21 (2 cycles)

CRT:

Oxal 85mg/m

2

Days 1, 15, 29 + Cape 625mg/m

2

bd Mon-Fri

45 Gy in 25 fractions

Restaging CT/PET-CT

Surgery (6-8 weeks post CRT)

© Universitätsmedizin Leipzig: University Cancer Center Leipzig (UCCL), Prof. Dr. F. Lordick

Mukherjee S et al.

ASCO-GI

2016

R

Cape

RT

Oxaliplatin

Carboplatin/Paclitaxel

Follow up: 6 weeks, 6 & 12 months

45 Gy in 25 fractions

CarPacRT Arm

:

Oxaliplatin 130mg/m

2

Day 1 + Capecitabine 625mg/m

2

bd Day 1- 21 (2 cycles)

CRT:

Paclitaxel 50mg/m

2

& Carboplatin AUC 2 Days 1,8,15,22,29;